Improving clinical trial outcomes in amyotrophic lateral sclerosis

Individuals who are diagnosed with amyotrophic lateral sclerosis (ALS) today face the same historically intransigent problem that has existed since the initial description of the disease in the 1860s — a lack of effective therapies. In part, the development of new treatments has been hampered by an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nat Rev Neurol
Hauptverfasser: Kiernan, Matthew C., Vucic, Steve, Talbot, Kevin, McDermott, Christopher J., Hardiman, Orla, Shefner, Jeremy M., Al-Chalabi, Ammar, Huynh, William, Cudkowicz, Merit, Talman, Paul, Van den Berg, Leonard H., Dharmadasa, Thanuja, Wicks, Paul, Reilly, Claire, Turner, Martin R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2020
Schlagworte:
Review Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747476/
https://ncbi.nlm.nih.gov/pubmed/33340024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-00434-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge